Evidence map›Paper›PMID 30048815›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2018

In vivo biodistribution and toxicology studies of cadmium-free indium-based quantum dot nanoparticles in a rat model.

Elnaz Yaghini, Helen Turner, Andrew Pilling, Imad Naasani, Alexander J MacRobert

Open access · hybridAbstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Interactions between Quantum Dots and G-Actin.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Review
  10. Quantum Dots and Their Interaction with Biological Systems.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Image-guided tumor surgery: The emerging role of nanotechnology.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elnaz YaghiniDivision of Surgery and Interventional Science, University College London, London, UK. Electronic address: elnaz.yaghini@ucl.ac.uk.
Helen TurnerNanoco Technologies Limited, Manchester, UK.
Andrew PillingToxPath Consultancy Limited, Stradbroke Business Centre, Eye, Suffolk, UK.
Imad NaasaniNanoco Technologies Limited, Manchester, UK.
Alexander J MacRobertDivision of Surgery and Interventional Science, University College London, London, UK.
Nanoco Technologies (United Kingdom) · GBUniversity College London · GB

Funding

Medical Research Council MC_PC_14093Wellcome Trust
6 · The paper itself

Abstract

Quantum dot (QD) nanoparticles are highly promising contrast agents and probes for biomedical applications owing to their excellent photophysical properties. However, toxicity concerns about commonly used cadmium-based QDs hinder their translation to clinical applications. In this study we describe the in vivo biodistribution and toxicology of indium-based water soluble QDs in rats following intravenous administration. The biodistribution measured at up to 90 days showed that QDs mainly accumulated in the liver and spleen, with similar elimination kinetics to subcutaneous administration. Evidence for QD degradation in the liver was found by comparing photoluminescence measurements versus elemental analysis. No organ damage or histopathological lesions were observed for the QDs treated rats after 24 h, 1 and 4 weeks following intravenous administration at 12.5 mg/kg or 50 mg/kg. Analysis of serum biochemistry and complete blood counts found no toxicity. This work supports the strong potential of indium-based QDs for translation into the clinic.

Indexed as

CadmiumAnimalsFemaleIndiumLiverModels, AnimalNanoparticlesQuantum DotsRatsTissue DistributionToxicity TestsCadmiumIndiumBiodistributionCadmium-free quantum dotsNanoparticlesToxicology

Identifiers

PMID30048815
PMCPMC6198065
OpenAlexW2883549528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.